
CBLL Stock Analysis
CeriBell, Inc
HEALTHCARE
MEDICAL DEVICES
Performance Overview
Trailing adjusted-close returns as of 2026-07-01. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 20, 2026
CBLL Stock Analysis: Why CeriBell, Inc Scored 50% in Stock Value Finder
CeriBell, Inc (CBLL): A Comprehensive StockValueFinder Review
CeriBell, Inc is a healthcare company operating within the medical devices industry. This detailed review aims to provide an educational analysis of CBLL based on its recent performance and metrics as evaluated by StockValueFinder. The goal here is not to recommend buying or selling but to help you understand how to evaluate stocks like CeriBell.
Why the StockValueFinder Score Matters
StockValueFinder evaluates companies across multiple financial metrics, assigning a score out of 100% that reflects overall financial health and valuation attractiveness. For CeriBell, Inc (CBLL), the current score is 50%, which translates to an AVOID rating. This score indicates that while there may be some positive attributes, the negatives outweigh them according to StockValueFinder's criteria.
EPS Strength and Consistency
Earnings Per Share (EPS) consistency is a critical metric for assessing a company’s profitability over time. In this case, CeriBell did not pass the EPS test because detailed historical EPS data was not provided by StockValueFinder. Typically, consistent positive EPS growth signals financial stability and efficiency in generating profits from operations.
**Example:** A company with steady EPS increases year-over-year demonstrates better earnings management compared to one showing erratic or declining figures.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) measures how effectively a company uses capital to generate returns. For CeriBell, the ROIC is -30.07%, which is significantly below StockValueFinder’s preferred threshold of 10% or higher. A lower ROIC suggests that the company is not efficiently utilizing its capital.
**Example:** An ROIC of 15% indicates better use of capital than an ROIC of 4%. This means for every dollar invested, a company with a higher ROIC generates more profit compared to one with a lower figure.
Interest Coverage and Financial Safety
Interest coverage ratio shows how easily a company can cover its interest expenses. CeriBell did not pass the interest coverage test because detailed information was not provided by StockValueFinder. Generally, an interest coverage of 6 or higher is preferred as it indicates financial stability.
**Example:** A company with an interest coverage of 8x has healthier finances than one with only 2x coverage since it can easily meet its debt obligations without strain on operations.
Debt Payback and Balance Sheet Discipline
The debt payback period measures how long a company would take to repay all its debts using current earnings. CeriBell’s debt payback is -0.48 years, which means the company theoretically repays its entire debt within less than one year based on current operations. StockValueFinder prefers debt payback periods of 3 years or shorter.
**Example:** A company with a debt payback period of 1.5 years uses its earnings more efficiently to reduce debt compared to one needing 7 years, indicating better financial discipline.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio compares the stock price to earnings per share, providing insight into valuation levels. CeriBell’s P/E is -28.13, which StockValueFinder considers acceptable since it passed this test despite being negative. A P/E of 15 or lower generally indicates a more value-oriented investment.
**Example:** A company with a P/E ratio of 8 may be considered undervalued compared to one trading at a P/E of 40, assuming similar business quality and growth prospects.
Moving Average Trend and Entry Timing
StockValueFinder uses moving average trends as part of its timing discipline criteria. CeriBell currently has a STRONG BUY TREND signal based on recent price movements relative to long-term averages. However, the entry signal is N/A, indicating no specific buy or sell recommendation at this time.
**Example:** A strong buy trend suggests that prices are rising above moving averages but does not guarantee future gains; it merely indicates favorable momentum for entry points if other criteria align positively.
Overall Financial Strengths and Weaknesses
CeriBell’s financial profile highlights several areas of concern
Risks and Limitations
Given CeriBell’s AVOID rating
Educational Conclusion
This review emphasizes the importance of evaluating multiple metrics when considering an investment in CeriBell. Key takeaways include understanding EPS consistency, ROIC for capital efficiency, interest coverage for financial safety, and P/E ratio for valuation discipline. While some aspects may appear favorable, overall financial health indicators suggest caution as per StockValueFinder’s criteria.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.